NRIX Nurix Therapeutics Earnings and EPS analysis

EPS in 2026 (TTM): $2.5

Last Report Period Date: Aug 31, 2026

As of November 2026, NRIX's current EPS stands at $2.5, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of -$3.05, which marks a drop compared to its EPS of -$2.88 in 2024. NRIX reported an EPS of $4.93 for the quarterly report ending on Aug 31, 2026.

For 2025, Nurix Therapeutics's EPS was -$3.05, a drop of 5.9% from -$2.88 in 2024. For the fiscal quarter that ended on Aug 31, 2026, the per-share earnings was $4.93, showing a 578.6% increase from the same quarter last year. For the twelve months ending August 2026, the EPS is $2.5. For the year 2024, the yearly earnings per share was -$2.88, marking a decrease of 8.7% from 2023.

During the last 12 months, Nurix Therapeutics has seen an EPS growth of 578.6% (YoY, quarterly).